We are live on
!
Find out more
Wealth Enhancement Advisory Services Portfolio holdings
AUM
$59.8B
1-Year Est. Return
29.42%
This Fund
S&P 500
This Quarter
Est. Return
+2.55%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$73.7B
AUM Growth
+$7.59B
(+11%)
Cap. Flow
+$5.52B
Cap. Flow
% of AUM
7.49%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
3,840
New
264
Increased
2,051
Reduced
1,186
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.53B |
| 2 |
Lam Research
LRCX
|
+$252M |
| 3 |
ALPS Smith Core Plus Bond ETF
SMTH
|
+$161M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$151M |
| 5 |
BRIF
FIS Bright Portfolios Focused Equity ETF
BRIF
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$127M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$106M |
| 3 |
Mastercard
MA
|
+$104M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
+$79.8M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$70.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.15% |
| 2 | Financials | 6.29% |
| 3 | Industrials | 4.43% |
| 4 | Healthcare | 4.03% |
| 5 | Consumer Discretionary | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
RPC Inc
RES
$1.36B
| $66.8K | ﹤0.01% |
+11,810
| New | +$61.4K |
|
|
VZLA
3502
Vizsla Silver
VZLA
$1.36B
| $65.3K | ﹤0.01% |
11,076
| – | – |
|
3503
GoodRx Holdings
GDRX
$1.25B
| $64.7K | ﹤0.01% |
+22,308
| New | +$73.2K |
|
3504
Rocket Pharmaceuticals
RCKT
$397M
| $64.5K | ﹤0.01% |
18,230
+1,102
| +6% | +$3.77K |
|
3505
Resources Connection
RGP
$145M
| $64.3K | ﹤0.01% |
+12,311
| New | +$58.7K |
|
3506
Iovance Biotherapeutics
IOVA
$2.9B
| $64.1K | ﹤0.01% |
25,150
-2,808
| -10% | -$6.5K |
|
3507
Vir Biotechnology
VIR
$1.5B
| $64.1K | ﹤0.01% |
10,747
-318
| -3% | -$1.89K |
|
3508
Falcon's Beyond Global Warrants
FBYDW
$10.9M
| $63.9K | ﹤0.01% |
31,956
| – | – |
|
3509
Community Health Systems
CYH
$415M
| $63.5K | ﹤0.01% |
17,269
+6,971
| +68% | +$23.4K |
|
3510
CALL
Grab
GRAB
$15B
| $63.2K | ﹤0.01% |
50,000
+5,000
| +11% | +$27.6K |
|
3511
Ameresco
AMRC
$1.34B
| $62.9K | ﹤0.01% |
2,257
+2
| +0.1% | +$70 |
|
3512
CALL
Nu Holdings
NU
$67B
| $62.7K | ﹤0.01% |
+10,000
| New | +$161K |
|
3513
Hertz
HTZ
$756M
| $62.3K | ﹤0.01% |
11,042
-1,401
| -11% | -$7.65K |
|
3514
PC Connection
CNXN
$2.08B
| $61.8K | ﹤0.01% |
1,064
-1,597
| -60% | -$95.1K |
|
3515
Stagwell
STGW
$2.22B
| $61K | ﹤0.01% |
+12,240
| New | +$63.7K |
|
3516
Futu Holdings
FUTU
$15.2B
| $60.7K | ﹤0.01% |
+342
| New | +$58.7K |
|
3517
Aura Biosciences
AURA
$796M
| $60.5K | ﹤0.01% |
11,724
-93
| -0.8% | -$552 |
|
|
EWCZ
3518
DELISTED
European Wax Center
EWCZ
| $60.4K | ﹤0.01% |
15,028
+505
| +3% | +$1.89K |
|
3519
Puma Biotechnology
PBYI
$442M
| $59.4K | ﹤0.01% |
+10,144
| New | +$53.9K |
|
3520
Gossamer Bio
GOSS
$86.1M
| $59.3K | ﹤0.01% |
23,964
+4,767
| +25% | +$13.6K |
|
3521
Anavex Life Sciences
AVXL
$314M
| $58.4K | ﹤0.01% |
14,553
+3,068
| +27% | +$18.8K |
|
|
HIX
3522
Western Asset High Income Fund II
HIX
$355M
| $57.9K | ﹤0.01% |
13,827
-429
| -3% | -$1.81K |
|
3523
Hyperfine
HYPR
$101M
| $57.8K | ﹤0.01% |
56,625
| – | – |
|
3524
Oramed Pharmaceuticals
ORMP
$175M
| $56.2K | ﹤0.01% |
18,299
-500
| -3% | -$1.29K |
|
3525
Clarivate
CLVT
$1.21B
| $56.2K | ﹤0.01% |
16,570
+252
| +2% | +$896 |
|
Similar funds
QCM
NAMI
Wealth Enhancement Advisory Services's Q4 2025 Portfolio in Review
As of Q4 2025, Wealth Enhancement Advisory Services held 3,840 positions worth $73.7B, up 11% from $66.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wealth Enhancement Advisory Services deployed $5.52B of net new capital in Q4 2025, opening 264 new positions and adding to 2,051 existing holdings. Its largest new stake was FIS Bright Portfolios Focused Equity ETF: 3,197,675 shares worth $97.2M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Accenture, an estimated $127M trimmed.
- Wealth Enhancement Advisory Services's largest Q4 2025 buy was FIS Bright Portfolios Focused Equity ETF: 3,197,675 shares worth $97.2M.
- Wealth Enhancement Advisory Services added most to Broadcom in Q4 2025, an estimated $2.53B increase.
- Wealth Enhancement Advisory Services's biggest Q4 2025 reduction was Accenture, cutting an estimated $127M.
- Wealth Enhancement Advisory Services fully exited iShares iBonds Dec 2025 Term Treasury ETF in Q4 2025, selling an estimated $13.2M.
- Wealth Enhancement Advisory Services's ten largest holdings make up 25% of its $73.7B portfolio in Q4 2025.
- Wealth Enhancement Advisory Services opened 264 new positions and closed 193 in Q4 2025.
- Wealth Enhancement Advisory Services's portfolio value rose 11% quarter-over-quarter to $73.7B.
Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2025, filed 8 Jan 2026.